Medicine Distribution Consents




116 NEW ZEALAND GAZETTE, No. 5 15 JANUARY 2009

Schedule

Product: Mencevax ACWY vaccine

Active Ingredients: Neisseria meningitidis, group A 50μg
Neisseria meningitidis, group C 50μg
Neisseria meningitidis, group W135 50μg
Neisseria meningitidis, group Y 50μg

Dosage Form: Powder for injection
Diluent

New Zealand Sponsor: GlaxoSmithKline (NZ) Limited

Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium

Dated this 9th day of January 2009.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go414


Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Aldurazyme

Active Ingredient: Laronidase 0.58mg/mL

Dosage Form: Concentrate for infusion

New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics

Manufacturer: BioMarin Pharmaceutical Inc, Novato, California, United States of America

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 9th day of January 2009.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go417


Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product: Proleukin

Active Ingredient: Aldesleukin 18MIU

Dosage Form: Powder for injection

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Note: This renewed consent is valid for two years from 27 January 2009.

Product: Proleukin

Active Ingredient: Aldesleukin 9MIU

Dosage Form: Powder for injection

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom

Note: This renewed consent is valid for two years from 27 January 2009.

Dated this 9th day of January 2009.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go416



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 5





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a New Medicine - Mencevax ACWY

🏥 Health & Social Welfare
9 January 2009
Medicines Act 1981, Vaccine, Distribution Consent, GlaxoSmithKline
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Provisional Consent to the Distribution of a New Medicine - Aldurazyme

🏥 Health & Social Welfare
9 January 2009
Medicines Act 1981, New Medicine, Distribution Consent, Pharmacy Retailing
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

🏥 Renewal of Provisional Consent to the Distribution of a Medicine - Proleukin

🏥 Health & Social Welfare
9 January 2009
Medicines Act 1981, Medicine Renewal, Distribution Consent, Novartis
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate